Farmacéuticos Comunitarios. 2017 Dec 30; 9(4):5-13 DOI: 10.5672/FC.2173-9218.(2017/Vol9).004.02

Evaluation of compliance with hypoglycemic and anti-hypertension treatments in Galicia (CumpleGa)

Fornos-Pérez JA1, Andrés-Rodríguez NF2, Andrés-Iglesias JC3, Mera-Gallego R4, Mera-Gallego I5, Penín-Álvarez O6, Brizuela-Rodicio L7
1. Doctor en Farmacia. Farmacéutico comunitario. Farmacia Fornos. Cangas do Morrazo (Pontevedra). Coordinador del Grupo de Diabetes de SEFAC. Grupo Berbés de Investigación y Docencia. www.grupoberbes.es 2. Doctor en Farmacia. Farmacéutico comunitario. Farmacia Andrés CB. Vigo. Miembro del Grupo de Diabetes de SEFAC. Grupo Berbés de Investigación y Docencia. www.grupoberbes.es 3. Farmacéutico comunitario. Farmacia Andrés CB. Vigo. Miembro del Grupo de Diabetes de SEFAC. Grupo Berbés de Investigación y Docencia. www.grupoberbes.es 4. Farmacéutica comunitaria. Farmacia Andrés CB. Vigo. Miembro del Grupo de Diabetes de SEFAC. Grupo Berbés de Investigación y Docencia. www.grupoberbes.es 5. Farmacéutica comunitaria. Farmacia Satué. Maella (Zaragoza). Miembro del Grupo de Diabetes de SEFAC. Grupo Berbés de Investigación y Docencia. www.grupoberbes.es 6. Farmacéutico comunitario. Farmacia Penín. Celanova (Ourense). 7. Licenciado en Medicina y Cirugía. Farmacéutico comunitario. Farmacia Brizuela. A Coruña.
Fornos-Pérez JA, Andrés-Rodríguez NF, Andrés-Iglesias JC, Mera-Gallego R, Mera-Gallego I, Penín-Álvarez O, Brizuela-Rodicio L. Valoración del cumplimiento de los tratamientos hipoglucemiantes y antihipertensivos en Galicia (‘CumpleGa’). Farmacéuticos Comunitarios. 2017 Dec 30; 9(4):5-13 DOI: 10.5672/FC.2173-9218.(2017/Vol9).004.02
Abstract : 

Objective: To evaluate the prevalence of therapeutic noncompliance in diabetes and arterial hypertension in Galician community pharmacies (FC), identifying the factors associated with patients' non-adherence and perception of their treatment.

Methods: A cross-sectional, descriptive, randomized study conducted in August and September 2016 among adult patients receiving treatment with hypoglycemic and/or antihypertensive drugs for at least two months with the same treatment regimen. Noncompliance was assessed with the administration of three questionnaires: Batalla, Haynes-Sacket y Morisky-Green, in one page of data collection that included the three questionnaires, as well as the demographic data of each patient.

Results: 31 community pharmacies participated in 27 pharmacies and collected 1,588 (sample size: 1,537) valid questionnaires: 778 (49.0%) females and 810 (51.0%) males, aged 67.6±11.1 years on average. The number of non-compliant patients at least in one of the three tests was 1,245 (78.4%). The average noncompliance was 42.6%. Treatment perception was negative for 35.6% of patients. 51.0% of patients ignore the complications of their illness, 33.1% forget to take their medication, and 29.5% do not believe their prescribed medications are suitable.

Conclusions: Noncompliance with the therapeutic guidelines for diabetic and hypertension medication in Galicia is high and affects nearly half the patient population.

Poor knowledge of the disease, lower level of education, multiple medication, pensioner age (elderly) and negative perception of medications seem to correlate with a higher prevalence of treatment noncompliance.

Article download link: